Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous T-Cells and PCV in Multiple Myeloma
NCT00046852Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2001
- Primary completion
- Nov 2004
- Countries
- 1
01
Overview
A Phase 2 trial of vaccine-primed, CD3/CD28-costimulated autologous peripheral blood T-cells in multiple myeloma (MM), sponsored by University of Maryland, Baltimore. Started Dec 2001; status: completed.
02
Drugs
vaccine-primed, CD3/CD28-costimulated autologous peripheral blood T-cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00046852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046852.